Search results for "ICAC"

showing 10 items of 3727 documents

Extracellular vesicles in multiple sclerosis as possible biomarkers: Dream or reality?

2017

Extracellular vesicles are recently described as specialized structures for intercellular communication. Their role in the central nervous system was diffusely studied in both physiological and pathological condition. In particular, an increased extracellular vesicle number was detected in several autoimmune diseases, including multiple sclerosis, a chronic autoimmune, inflammatory, demyelinating and neurodegenerative disease. This chapter summarizes the available information on the involvement of the extracellular vesicles in multiple sclerosis pathogenesis and their possible use as biomarker of therapy efficacy.

0301 basic medicinePathologymedicine.medical_specialtybusiness.industryMultiple sclerosisCentral nervous systemExtracellular vesicleDiseaseBiomarkermedicine.diseasePathogenesisTherapy efficacy03 medical and health sciences030104 developmental biology0302 clinical medicinemedicine.anatomical_structuremedicineBiomarker (medicine)Multiple sclerosiExtracellular vesiclebusinessPathological030217 neurology & neurosurgeryIntracellular
researchProduct

Urtica dioica pollen allergy

2016

Abstract Background The most emblematic members of Urticaceae at allergic risk level are wall pellitories ( Parietaria ), whereas nettle ( Urtica ) pollen is considered as poorly allergenic. No allergen from nettle pollen has yet been characterized, whereas 4 are listed for Parietaria pollen by the International Union of Immunological Societies. Clinical and biological profiles of 2 adult men who developed symptoms against nettle pollen and/or leaves were studied. Objective To characterize the allergic reaction and identify the potential nettle pollen sensitizing allergens. Methods IgE-mediated reaction to nettle pollen extract was evaluated by skin prick test, immunoassay, nasal provocatio…

0301 basic medicinePulmonary and Respiratory MedicineAllergyfood.ingredientParietariabiologymedicine.medical_treatmentImmunologyUrticafood and beveragesbiology.organism_classificationmedicine.disease_causemedicine.diseaseNasal provocation testUrticaceae03 medical and health sciencesBasophil activation030104 developmental biologyfoodAllergenPollenImmunologyotorhinolaryngologic diseasesmedicineImmunology and AllergyAnnals of Allergy, Asthma & Immunology
researchProduct

The Novel Oral Anticoagulants for Acute Venous Thromboembolism: Is Warfarin Dead?

2017

The direct oral anticoagulants (DOACs) have been compared with parenteral anticoagulants and vitamin K antagonists (VKAs) for the treatment of venous thromboembolism (VTE) in several robust studies. DOACs have shown similar efficacy in preventing recurrent VTE and significant reductions in critical site (intracranial) bleeding, fatal bleeding, major and nonmajor bleeding. Warfarin and other VKAs are not dead as treatment modalities for VTE. A better way to describe the current situation is to use a boxing expression, “down but not out.” VKAs and parenteral anticoagulants still have a role to play in the management of VTE in several clinical settings. In indications where DOACs can be used, …

0301 basic medicinePulmonary and Respiratory Medicinemedicine.medical_specialtyAdministration OralClinical settingsVitamin kCritical Care and Intensive Care Medicine03 medical and health sciences0302 clinical medicineSecondary PreventionmedicineHumanscardiovascular diseasesIntensive care medicineOral anticoagulationCerebral Hemorrhagebusiness.industryWarfarinAnticoagulantsVenous ThromboembolismSafety profile030104 developmental biologyTreatment modalityvenous thromboembolism oral anticoagulation warfarin non-VKA oral anticoagulants safety efficacy030220 oncology & carcinogenesisWarfarinbusinessVenous thromboembolismmedicine.drug
researchProduct

Spectrophotometric analysis of crown discoloration following the use of silver nanoparticles combined with calcium hydroxide as intracanal medicament

2017

Background Optimal antibacterial efficacy of intracanal medicaments containing silver nanoparticles (Ag-NPs) has been well documented. However, concerns remain regarding the effect of Ag-NPs on tooth color. This study aimed to assess the effects of calcium hydroxide (CH) mixed with Ag-NPs as intracanal medicaments on tooth color. The effect of location of application of medicament on the degree of discoloration was evaluated as well. Material and Methods Fifty extracted single-rooted, single-canal human teeth with straight roots, no caries, no cracks or fractures were collected and accessed. After cleaning and shaping of the root canals, the teeth were randomly divided into two experimental…

0301 basic medicineRoot canalmedicine.medical_treatmentCemento-enamel junctionDentistryAntibacterial efficacySilver nanoparticleCrown (dentistry)Operative Dentistry and Endodontics03 medical and health scienceschemistry.chemical_compound0302 clinical medicinemedicineGeneral DentistrySalineCalcium hydroxidebusiness.industryResearch030206 dentistry:CIENCIAS MÉDICAS [UNESCO]030104 developmental biologymedicine.anatomical_structurechemistryUNESCO::CIENCIAS MÉDICASTooth colorbusiness
researchProduct

Daclatasvir-based regimens in HCV cirrhosis: experience from the Italian early access program

2019

AbstractWe reported the efficacy and safety data for daclatasvir (DCV)-based all-oral antiviral therapy in patients treated in the Italian compassionate-use program. 275 patients were included (202 male-73.5%, mean age: 57.4 years, 62 HIV-coinfected, 94 with recurrence of hepatitis C post-OLT). Forty-nine patients (17.8%) had Child-Pugh B, Genotype(G) distribution was: G1a:72 patients (26.2%), G1b:137 (49.8%); G3:40 (14.5%) and G4:26 (9.5%). Patients received DCV with sofosbuvir(SOF) (n = 221, 129 with ribavirin(RBV) or with simeprevir (SMV) or asunaprevir (ASU) (n = 54, 19 with RBV) for up to 24 weeks. Logistic regression was used to identify baseline characteristics associated with sustai…

0301 basic medicineSimeprevirLiver CirrhosisMalePyrrolidinesSofosbuvirSustained Virologic Responselcsh:MedicineSettore MED/05Gastroenterologychemistry.chemical_compound0302 clinical medicineLiver Function TestsINFECTIONMedicinePLUS SOFOSBUVIRlcsh:ScienceSulfonamidesMultidisciplinaryImidazolesValineHepatitis CMiddle AgedTreatment OutcomeItalySAFETYHCVSUSTAINED VIROLOGICAL RESPONSEDrug Therapy CombinationFemaleRIBAVIRINSettore BIO/19 - MICROBIOLOGIA GENERALECHRONIC HEPATITIS-Cmedicine.drugAdultmedicine.medical_specialtyDaclatasvirDrug-Related Side Effects and Adverse ReactionsAntiviral AgentsArticle03 medical and health sciencesInternal medicineHumansAgedADVANCED LIVER-DISEASEbusiness.industryRibavirinVIRUS GENOTYPE 3lcsh:RHepatitis C ChronicHCV HIV Daclatasvirmedicine.diseaseIsoquinolinesEFFICACYRegimen030104 developmental biologychemistryAsunaprevirlcsh:QLiver functionCarbamatesSofosbuvirbusiness030217 neurology & neurosurgeryScientific Reports
researchProduct

Strategic Syntheses of Vine and Wine Resveratrol Derivatives to Explore their Effects on Cell Functions and Dysfunctions

2018

Trans-resveratrol, the most well-known polyphenolic stilbenoid, is found in grapes and accordingly in wine and it is considered to be beneficial for human health, especially towards the aging-linked cell alterations by providing numerous biological activities, such as anti-oxidant, antitumoral, antiviral, anti-inflammatory, neuroprotective, and platelet anti-aggregation properties. Although trans-resveratrol is a promising molecule, it cannot be considered as a drug, due to its weak bio-availability and fast metabolism. To overcome these weaknesses, several research teams have undertaken the synthesis of innovative trans-resveratrol derivatives, with the aim to increase its solubility in wa…

0301 basic medicineWineSynthetic derivativesChemistrylcsh:Rlcsh:Medicinefood and beveragesReviewComputational biologybiological targetsResveratrolStilbenoidsubstituents phenyl ringsCell functionsynthesis strategies03 medical and health sciencesHuman healthchemistry.chemical_compound030104 developmental biologyresveratrol derivativesefficacy towards diseasesOrganismDiseases
researchProduct

Bioavailability of Glucosinolates and Their Breakdown Products: Impact of Processing.

2016

International audience; Glucosinolates are a large group of plant secondary metabolites with nutritional effects, and are mainly found in cruciferous plants. After ingestion, glucosinolates could be partially absorbed in their intact form through the gastrointestinal mucosa. However, the largest fraction is metabolized in the gut lumen. When cruciferous are consumed without processing, myrosinase enzyme present in these plants hydrolyzes the glucosinolates in the proximal part of the gastrointestinal tract to various metabolites, such as isothiocyanates, nitriles, oxazolidine-2-thiones, and indole-3-carbinols. When cruciferous are cooked before consumption, myrosinase is inactivated and glu…

0301 basic medicineisothiocyanates[SDV.BIO]Life Sciences [q-bio]/Biotechnologybrassicaceaeprocessing.[SDV]Life Sciences [q-bio]Endocrinology Diabetes and Metabolismlcsh:TX341-641Gastrointestinal mucosaReviewBiology03 medical and health sciences0302 clinical medicineJournal ArticleIngestion[SPI.GPROC]Engineering Sciences [physics]/Chemical and Process EngineeringFood scienceglucosinolatesNutritionchemistry.chemical_classificationGastrointestinal tractNutrition and DieteticsMyrosinasemyrosinaseAssimilation (biology)Brassicaceaebiology.organism_classificationBioavailability030104 developmental biologyEnzymechemistryBiochemistry030220 oncology & carcinogenesisprocessingbioavailability[SDV.AEN]Life Sciences [q-bio]/Food and Nutritionlcsh:Nutrition. Foods and food supplyFood ScienceFrontiers in nutrition
researchProduct

Taxonomic Classification for Living Organisms Using Convolutional Neural Networks

2017

Taxonomic classification has a wide-range of applications such as finding out more about evolutionary history. Compared to the estimated number of organisms that nature harbors, humanity does not have a thorough comprehension of to which specific classes they belong. The classification of living organisms can be done in many machine learning techniques. However, in this study, this is performed using convolutional neural networks. Moreover, a DNA encoding technique is incorporated in the algorithm to increase performance and avoid misclassifications. The algorithm proposed outperformed the state of the art algorithms in terms of accuracy and sensitivity, which illustrates a high potential f…

0301 basic medicinelcsh:QH426-470Taxonomic classificationADNCodificació Teoria de laBiologyBioinformaticsMachine learningcomputer.software_genreDNA; genes; taxonomic classification; convolutional neural networks; encodingConvolutional neural networkArticle03 medical and health sciences0302 clinical medicineBiologia -- ClassificacióEncoding (memory)convolutional neural networksGeneticstaxonomic classificationSensitivity (control systems)genesGenetics (clinical)ta113Biology -- Classificationbusiness.industryBiological classificationCoding theoryDNAencodinglcsh:Genetics030104 developmental biologyGenes030220 oncology & carcinogenesisEncodingConvolutional neural networksArtificial intelligenceCoding theorybusinesscomputerGens
researchProduct

Comparative Effectiveness of Multiple Different First-Line Treatment Regimens for Helicobacter pylori Infection: A Network Meta-analysis

2021

Background & Aims A number of double, triple, and quadruple therapies have been proposed as first-line empiric treatments for Helicobacter pylori infection. However, knowledge of their worldwide and regional comparative efficacy is lacking. We examined the comparative effectiveness of all empirically used first-line regimens tested against standard triple treatment using a network meta-analysis of published randomized controlled trials. Methods Data extracted from eligible randomized controlled trials were entered into a Bayesian network meta-analysis to investigate the comparative efficacy of H pylori infection empiric first-line regimens and to explore their effectiveness rank order. The …

0301 basic medicinemedicine.medical_specialtyComparative Effectiveness ResearchTime FactorsEfficacyVonoprazanSettore MED/12 - GASTROENTEROLOGIANetwork Meta-Analysislaw.inventionHelicobacter Infections03 medical and health sciences0302 clinical medicineRandomized controlled trialDrug TherapyLevofloxacinlawInternal medicinemedicineHumansFirst-Line RegimensRandomized Controlled Trials as TopicHepatologybiologyHelicobacter pyloribusiness.industryRemission InductionSettore MED/09 - MEDICINA INTERNAGastroenterologyBayes TheoremProton Pump InhibitorsOdds ratioHelicobacter pyloribiology.organism_classificationConfidence intervalAnti-Bacterial AgentsTreatmentRegimen030104 developmental biologyTreatment OutcomeMeta-analysisCombination030211 gastroenterology & hepatologyDrug Therapy Combinationbusinessmedicine.drug
researchProduct

Development of artemisinin resistance in malaria therapy

2019

Malaria affects 200 million people worldwide. Today, the most successful treatments are artemisinin-based combination therapies (ACT). Resistance has already been described for the elder anti-malarials chloroquine, sulfadoxine-pyrimethamine and mefloquine. Unfortunately, over the last few years there has also been an emerging resistance to the successfully used drug artemisinin, especially in African and Asian countries. A systematic PubMed literature research was conducted for studies published between January 2002 and December 2018. Despite ACTs continue to be first line treatment, the number of studies is rising reporting on artemisinin resistance mutations. Most publications reported on…

0301 basic medicinemedicine.medical_specialtyDrug ResistanceAntimalarials03 medical and health sciences0302 clinical medicineChloroquineparasitic diseasesAsian countryAnimalsHumansMedicineArtemisininIntensive care medicinePharmacologyPolymorphism Geneticbusiness.industryMefloquineArtemisinin resistancemedicine.diseaseArtemisininsTreatment efficacyMalariaFirst line treatment030104 developmental biology030220 oncology & carcinogenesisMutationbusinessMalariamedicine.drugPharmacological Research
researchProduct